|
There
are three general categories of "rules" to follow in practicing
bariatric medicine in Florida:
1.
All federal and Drug Enforcement Administration (DEA) Acts concerning
the prescription of controlled substances.
2.
Specific rules affecting only physicians licensed and practicing in
Florida, as promulgated by the Florida Board of Medicine.
3.
Generally accepted standards of medical care, which may vary from state
to state. Professional medical societies, such as the American Society
of Bariatric Physicians and the Florida Society of Bariatric Physicians
help clarify and establish such standards.
In addition to many applicable rules from the Florida Board of Medicine, Bariatric physicians prescribing appetite suppressants should be aware they are also under the jurisdiction of the DEA. The Federal rules are many and complex, but the U.S. Government Dept of Justice has a website that gives some explanation of the rules to prevent illegal diversion of controlled substances.
Also be aware that while Florida is one of the few states that allow non-doctors to own medical clinics, it has recently passed a series of laws regulating such entities and the necessary level of medical supervision. This leads to problems when a Florida licensed doctor is hired by a business owner, which may occur when a Medi-Spa,
Nutrition/Vitamin Shop, or Grooming Salon owner decides to go into the weight management business. Such an employed doctor remains responsible for medical claims in advertisements (even though the owner, not the doctor, places the ads) and all DEA related drug activities such as ordering, prescribing and dispensing (there are many Federal restrictions on purchasing/shipping controlled drugs and Florida has recently added new detailed rules for shipping drugs across borders into this state). An unscrupulous business owner could use the employed doctor's DEA number and instruct staff to order and dispense under that number, without clearly explaining to the doctor what is happening. Be aware the DEA is in the Enforcement (and Conviction) business, not the Explaining business, and the licensed doctor remains responsible and must understand how drugs are being ordered and distributed under the DEA permit. Moreover, the Florida Board of Medicine vigilantly enforces the rules that require the physician, not physician extender, to personally examine any patient for whom controlled substances are prescribed. A Florida attorney skilled in medical business may be necessary to explain specific situations.
Select
from the links below to read the regulations that pertain especially to
physicians practicing bariatrics in the state of Florida:
Crimes
- Drug Abuse Prevention And Control (Part I)
Crimes - Drug Abuse Prevention And Control (Part II)
Regulation Of Professions And Occupations - Pharmacy
(Part I)
Regulation Of Professions And Occupations - Pharmacy
(Part II)
Standards for the Prescription of Obesity Drugs
Registration Fee for Dispensing Practitioners
Advertising
Pharmacy Practice
Medical Practice (Part I)
Medical Practice (Part II)
Title XLVI - Crimes
Chapter 893 - Drug Abuse Prevention And Control
View
Entire Chapter
893.06 Distribution of controlled substances; order forms; labeling and
packaging requirements
(1)
Controlled substances in Schedules I and II shall be distributed by a
duly licensed manufacturer, distributor, or wholesaler to a duly licensed
manufacturer, wholesaler, distributor, practitioner, pharmacy, as defined
in chapter 465, hospital, or laboratory only pursuant to an order form.
It shall be deemed a compliance with this subsection if the parties to
the transaction have complied with federal law respecting the use of order
forms.
(2)
Possession or control of controlled substances obtained as authorized
by this section shall be lawful if in the regular course of business,
occupation, profession, employment, or duty.
(3)
A person in charge of a hospital or laboratory or in the employ of this
state or of any other state, or of any political subdivision thereof,
and a master or other proper officer of a ship or aircraft, who obtains
controlled substances under the provisions of this section or otherwise,
shall not administer, dispense, or otherwise use such controlled substances
within this state, except within the scope of her or his employment or
official duty, and then only for scientific or medicinal purposes and
subject to the provisions of this chapter.
(4)
It shall be unlawful to distribute a controlled substance in a commercial
container unless such container bears a label showing the name and address
of the manufacturer, the quantity, kind, and form of controlled substance
contained therein, and the identifying symbol for such substance, as required
by federal law. No person except a pharmacist, for the purpose of dispensing
a prescription, or a practitioner, for the purpose of dispensing a controlled
substance to a patient, shall alter, deface, or remove any labels so affixed.
History.--s.
6, ch. 73-331; s. 1438, ch. 97-102.
Back
to Top
Title
XLVI - Crimes
Chapter 893 - Drug Abuse Prevention And Control
View
Entire Chapter
893.04
Pharmacist and practitioner
(1)
A pharmacist, in good faith and in the course of professional practice
only, may dispense controlled substances upon a written or oral prescription
of a practitioner, under the following conditions:
(a)
Oral prescriptions must be promptly reduced to writing by the pharmacist.
(b)
The written prescription must be dated and signed by the prescribing
practitioner on the day when issued.
(c)
There shall appear on the face of the prescription or written record
thereof for the controlled substance the following information:
1.
The full name and address of the person for whom, or the owner of
the animal for which, the controlled substance is dispensed.
2.
The full name and address of the prescribing practitioner and the
practitioner's federal controlled substance registry number shall
be printed thereon.
3.
If the prescription is for an animal, the species of animal for which
the controlled substance is prescribed.
4.
The name of the controlled substance prescribed and the strength,
quantity, and directions for use thereof.
5.
The number of the prescription, as recorded in the prescription files
of the pharmacy in which it is filled.
6.
The initials of the pharmacist filling the prescription and the date
filled.
(d)
The prescription shall be retained on file by the proprietor of the
pharmacy in which it is filled for a period of 2 years.
(e)
Affixed to the original container in which a controlled substance is
delivered upon a prescription or authorized refill thereof, as hereinafter
provided, there shall be a label bearing the following information:
1.
The name and address of the pharmacy from which such controlled substance
was dispensed.
2.
The date on which the prescription for such controlled substance was
filled.
3.
The number of such prescription, as recorded in the prescription files
of the pharmacy in which it is filled.
4.
The name of the prescribing practitioner.
5.
The name of the patient for whom, or of the owner and species of the
animal for which, the controlled substance is prescribed.
6.
The directions for the use of the controlled substance prescribed
in the prescription.
7.
A clear, concise warning that it is a crime to transfer the controlled
substance to any person other than the patient for whom prescribed.
(f)
A prescription for a controlled substance listed in Schedule II may
be dispensed only upon a written prescription of a practitioner, except
that in an emergency situation, as defined by regulation of the Department
of Health, such controlled substance may be dispensed upon oral prescription.
No prescription for a controlled substance listed in Schedule II may
be refilled.
(g)
No prescription for a controlled substance listed in Schedules III,
IV, or V may be filled or refilled more than five times within a period
of 6 months after the date on which the prescription was written unless
the prescription is renewed by a practitioner.
(2)
Notwithstanding the provisions of subsection (1), a pharmacist may dispense
a one-time emergency refill of up to a 72-hour supply of the prescribed
medication for any medicinal drug other than a medicinal drug listed in
Schedule II, in compliance with the provisions of s. 465.0275.
(3)
The legal owner of any stock of controlled substances in a pharmacy, upon
discontinuance of dealing in controlled substances, may sell said stock
to a manufacturer, wholesaler, or pharmacy. Such controlled substances
may be sold only upon an order form, when such an order form is required
for sale by the drug abuse laws of the United States or this state, or
regulations pursuant thereto.
History.--s.
4, ch. 73-331; s. 2, ch. 75-18; s. 12, ch. 79-12; s. 2, ch. 90-2; s. 1436,
ch. 97-102; s. 301, ch. 99-8.
Back
to Top
Title
XXXII - Regulation Of Professions And Occupations
Chapter 465 - Pharmacy
View
Entire Chapter
465.0276
Dispensing practitioner
(1)
A person may not dispense medicinal drugs unless licensed as a pharmacist
or otherwise authorized under this chapter to do so, except that a practitioner
authorized by law to prescribe drugs may dispense such drugs to her or
his patients in the regular course of her or his practice in compliance
with this section.
(2)
A practitioner who dispenses medicinal drugs for human consumption for
fee or remuneration of any kind, whether direct or indirect, must:
(a)
Register with her or his professional licensing board as a dispensing
practitioner and pay a fee not to exceed $100 at the time of such registration
and upon each renewal of her or his license. Each appropriate board
shall establish such fee by rule.
(b)
Comply with and be subject to all laws and rules applicable to pharmacists
and pharmacies, including, but not limited to, this chapter and chapters
499 and 893 and all federal laws and federal regulations.
(c)
Before dispensing any drug, give the patient a written prescription
and orally or in writing advise the patient that the prescription may
be filled in the practitioner's office or at any pharmacy.
(3)
The department shall inspect any facility where a practitioner dispenses
medicinal drugs pursuant to subsection (2) in the same manner and with
the same frequency as it inspects pharmacies for the purpose of determining
whether the practitioner is in compliance with all statutes and rules
applicable to her or his dispensing practice.
(4)
The registration of any practitioner who has been found by her or his
respective board to have dispensed medicinal drugs in violation of this
chapter shall be subject to suspension or revocation.
(5)
A practitioner who confines her or his activities to the dispensing of
complimentary packages of medicinal drugs to the practitioner's own patients
in the regular course of her or his practice, without the payment of fee
or remuneration of any kind, whether direct or indirect, and who herself
or himself dispenses such drugs is not required to register pursuant to
this section. The practitioner must dispense such drugs in the manufacturer's
labeled package with the practitioner's name, patient's name, and date
dispensed, or, if such drugs are not dispensed in the manufacturer's labeled
package, they must be dispensed in a container which bears the following
information:
(a)
Practitioner's name;
(b)
Patient's name;
(c)
Date dispensed;
(d)
Name and strength of drug; and
(e)
Directions for use.
History.--ss.
20, 27, ch. 86-256; s. 1, ch. 88-159; s. 59, ch. 91-137; s. 6, ch. 91-156;
s. 4, ch. 91-429; s. 95, ch. 92-149; s. 248, ch. 97-103.
Back
to Top
Title
XXXII - Regulation Of Professions And Occupations
Chapter 465 - Pharmacy
View
Entire Chapter
465.024
Promoting sale of certain drugs prohibited
(1)
It is declared that the unrestricted use of certain controlled substances,
causing abnormal reactions that may interfere with the user's physical
reflexes and judgments, may create hazardous circumstances which may cause
accidents to the user and to others, thereby affecting the public health,
safety, and welfare. It is further declared to be in the public interest
to limit the means of promoting the sale and use of these drugs. All provisions
of this section shall be liberally construed to carry out these objectives
and purposes.
(2)
No pharmacist, owner, or employee of a retail drug establishment shall
use any communication media to promote or advertise the use or sale of
any controlled substance appearing in any schedule in chapter 893.
(3)
This section shall not prohibit the advertising of any medicinal drugs,
other than those controlled substances specified in chapter 893, or any
patent or proprietary preparation, provided the advertising is not false,
misleading, or deceptive.
History.--ss.
1, 7, ch. 79-226; ss. 2, 3, ch. 81-318; ss. 26, 27, ch. 86-256; s. 59,
ch. 91-137; s. 6, ch. 91-156; s. 4, ch. 91-429.
Back
to Top
64
FL ADC 64B8-9.012
Rule 64B8-9.012, F.A.C.
Fla. Admin. Code Ann. r. 64B8-9.012
Florida
Administrative Code - Annotated
Title 64. Department of Health
Subtitle 64B8. Board of Medicine
Chapter 64B8-9. Standards of Practice for Medical Doctors
64B8-9.012
Standards for the Prescription of Obesity Drugs
The
prescription of medication for the purpose of enhancing weight loss should
only be performed by physicians qualified by training and experience to
treat obesity. All licensees are expected to abide by the following guidelines
and standards in the utilization of any drug, any synthetic compound,
any nutritional supplement or herbal treatment, for the purpose of providing
medically assisted weight loss.
(1)
To justify the use of weight loss enhancers as set forth above, the patient
must have a Body Mass Index (BMI) of 30 or above, or a BMI of greater
than 27 with at least one comorbidity factor, or a measurable body fat
content equal to or greater than 25% of total body weight for male patients
or 300/o of total body weight for women. The prescription of such weight
loss enhancers is not generally appropriate for children. Any time such
prescriptions are made for children, the prescribing physician must obtain
a written informed consent from the parent or legal guardian of the minor
patient in addition to complying with the other guidelines and standards
set forth in this rule. BMI is calculated by use of the formula BMI =
kg/m2.
(2)
Physicians in Florida are prohibited from prescribing, ordering, dispensing,
or administering any weight loss enhancer that is both a serotonergic
and anorexic agent unless the drug has been approved by the Food and Drug
Administration (FDA) specifically for use in weight loss management. Selective
serotonin re-uptake inhibitors (SSRIS) that have not been approved by
the FDA for weight loss may not be prescribed, ordered, dispensed, or
administered for such purposes.
(3)
An initial evaluation of the patient shall be conducted prior to the prescribing,
ordering, dispensing, or administering of any drug, synthetic compound,
nutritional supplement or herbal treatment and such evaluation shall include
an appropriate physical and complete history, appropriate tests related
to medical treatment for weight loss; and appropriate medical referrals
as indicated by the physical history, and testing; all in accordance with
general medical standards of care.
(a)
The initial evaluation may be delegated to an appropriately educated
and trained physicians assistant licensed pursuant to Chapter 458, Florida
Statutes, or an appropriately educated and trained advanced registered
nurse practitioner licensed pursuant to Chapter 464, Florida Statutes.
(b)
If the initial evaluation required above is delegated to a physicians
assistant or to an advance registered nurse practitioner, then the delegating
physician must personally review the resulting medical records prior
to the issuance of an initial prescription, order, or dosage.
(4)
Prescriptions or orders for any drug, synthetic compound, nutritional
supplement or herbal treatment for the purpose of assisting in weight
loss must be in writing and signed by the prescribing physician, Initial
prescriptions or orders of this " shall not be called into a pharmacy
by the physician or by an agent of the physician. Even if the physician
is registered as a dispensing physician, a hard copy of the written prescription
must be maintained in the patients medical records for each time such
weight loss enhancers are prescribed, ordered, dispensed, or administered
(5)
At the time of delivering the initial prescription or providing the initial
supply of such drugs to a patient, the prescribing physician must personally
meet with the patient and personally obtain an appropriate written informed
consent from the patient Such consent must state that there is a lack
of scientific data regarding the potential danger of long term use of
combination weight loss treatments, and shall discuss potential benefits
versus potential risks of weight loss treatments. The written consent
must also clearly state the need for dietary intervention and physical
exercise as a part of any weight loss regimen. A copy of the signed informed
consent shall be included in the patient s permanent medical record.
(6)
Each physician who is prescribing, ordering, or providing weight loss
enhancers to patients must assure that such patients undergo an in-person
reevaluation within 2 to 4 weeks of receiving a prescription, order, or
dosage. The re-evaluation shall include the elements of the initial evaluation
and an assessment of the medical effects of the treatment being provided.
Any patient that continues on a drug, synthetic compound, nutritional
supplement or herbal treatment assisted weight loss program shall be reevaluated
at least once every 3 months.
(7)
Each physician who prescribes, orders, dispenses, or administers any drug,
synthetic compound, nutritional supplement or herbal treatment for the
purpose of assisting a patient in weight loss shall maintain medical records
in compliance with Rule 64B8-9.003, Florida Administrative Code, and must
also reflect compliance with all requirements of this rule.
(8)
Each physician who prescribes, orders, dispenses, or administers weight
loss enhancers for the purpose of providing medically assisted weight
loss shall provide to each patient a legible copy of the Weight-Loss Consumer
Bill of Rights as set forth in Section 501.0575(l)(a) through (e)3., Florida
Statutes. The physician shall also conspicuously post said document in
those rooms wherein patients are evaluated for weight loss treatment
(9)
Any physician who advertises practice relating to weight loss or whose
services are advertised by another person or entity shall be responsible
for assuring that such advertising meets the requirements of Rule 64B8-1
1. 001, Florida Administrative Code. In addition advertising of weight
loss treatment shall be considered false, deceptive, or misleading if
it contains representations that:
(a)
Promise specific results;
(b)
Raise unreasonable expectations;
(c)
Claim rapid, dramatic, incredible, or safe weight loss;
(d)
State or suggest that diets or exercise are not required; or
(e)
Suggest that weight loss is effortless or magical.
Specific
Authority 458.336 FS. Law implemented 458.336 FS. History---New 12-4-97,
Amended 2-17-98. 64 FL ADC 64B8-9.012
Back
to Top
FL-ADC
- 64 FL ADC 64B8-3.006 Rule 64B8-3.006, F.A.C.
Fla.
Admin. Code Ann. r. 64B8-3.006
Florida
Adminitrative Code - Annotated
Title 64. Department of Health
Subtitle 64B8. Board of Medicine
Chapter 64B8-3. Fees
64B8-3.006
Registration Fee for Dispensing Practitioners
Every
practitioner who dispenses medicinal drugs for human consumption to his
or her patients in the regular course of practice for fee or remuneration
of any kind, whether direct or indirect, must register and pay a fee of
$100.00 at the time of registration and upon renewal of his or her license.
Specific
Authority > 458.309 FS. Law Implemented > 465.0276 FS, as amended
by s. 95, Ch. 92-149, Laws of Florida. History--New 11-15-88, Amended
11-30- 92, Formerly 21M-19.006, 6IF6-19.006, 59R-3.006. 64
FL ADC 64B8-3.006
Back
to Top
64
FL ADC 64B8-1 1. 001
Rule 64B8-1 1.001, F.A-C.
Fla. Admin. Code Ann. r. 64B8-11.001
Florida
Administrative Code - Annotated
Title 64. Department of Health
Subtitle 64B8. Board of Medicine
Chapter 64B8-11. Advertising
64B8-1
1.001 Advertising
(1)
The Board permits the dissemination to the public of legitimate information,
in accordance with the Board's rules, regarding the practice of medicine
and where and from whom medical services may be obtained, so long as such
information is in no way false, deceptive, or misleading.
(2)
No physician shall disseminate or cause the dissemination of any advertisement
or advertising which is in any way false, deceptive, or misleading Any
advertisement or advertising shall be deemed by the Board to be false,
deceptive, or misleading if it:
(a)
Contains a misrepresentation of facts; or
(b)
Makes only a partial disclosure of relevant facts; or
(e)
Creates false or unjustified expectations Of
beneficial assistance; or
(d)
Contains any representation or claims, as to which the physician, referred
to in the advertising, does not expect to perform; or
(e)
Contains any other representation, statement, or claim which misleads
or deceives; or
(f)
States or implies that the physician has received formal recognition
as a specialist in any aspect of the practice of medicine unless the
physician has in fact received such recognition and such recognizing
agency
is approved by the Board. However, a physician may use on letterhead
or in advertising a reference to the physician's specialty recognition
received from a recognizing agency that has not been approved by the
Board only if the letterhead or advertising also contains in the same
print size or volume the statement that "The specialty recognition
identified herein has been received from a private organization not
affiliated with or recognized by the Florida Board of Medicine."
For purposes of this rule, the Board approves the specialty boards of
the American Board of Medical Specialties (ABMS) as recognizing agencies,
and such other recognizing agencies as may request and receive future
approval by the Board based upon the following criteria:
1.
The recognizing agency must be an independent body that certifies
members as having advanced qualifications in a particular allopathic
medical specialty through peer-reviewed demonstrations of competence
in the specialty being recognized,
2.
Specialty recognition must require completion of an allopathic medical
residency program approved by either the Accreditation Council of
Graduate Medical Education (ACGUE) or the Royal College of Physicians
and Surgeons of Canada that includes substantial and identifiable
training in the allopathic specialty being recognized
3.
Specialty recognition must require successful completion of a comprehensive
examination administered by the recognizing agency pursuant to written
procedures that ensure adequate security and appropriate grading standards,
4.
The recognizing agency, if it is not an ABMS board, must require as
part of its certification requirement that each member receiving certification
be currently certified by a specialty board of the ABMS.
5.
The recognizing agency must have been determined by the Internal Revenue
Service of the United States to be a legitimate not for profit entity
pursuant to Section 501(c) of the Internal Revenue Code.
6.
The recognizing agency must have full time administrative staff, housed
in dedicated office space which is appropriate for the agency's program
and sufficient for responding to consumer or regulatory inquiries.
7.
The recognizing agency must have written by-laws, and a code of ethics
to guide the practice of its members and an internal review and control
process including budgetary Practices, to ensure effective utilization
of resources.
However,
a physician may indicate the services offered and may state that practice
is limited to one or more bills of services when this is in fact the
case; or
(g)
Represents that professional services can or will be competently performed
for a stated fee when this is not the case, or makes representations
with respect to fees for professional services that do not disclose
all variables affecting the fees that will in fact be charged; or
(h)
Conveys the impression that the physician disseminating the advertising
or referred to therein possesses qualifications, skills, or other attributes,
which are superior to other physicians, other than a simple listing
of earned professional post-doctoral or other professional achievements
recognized by the Board; or
(i)
Fails to conspicuously identify the physician by name in the advertisement;
or
(j)
Includes reference to specialty certification without identifying the
name of the specialty board that has awarded specialty certification;
or
(k)
Implies specialty or sub-specialty for which the physician has not received
specialty recognition.
(3)
As used in the rules of this Board, the terms of advertisement" and
"advertising" shall mean any statements, oral or written, disseminated
to or before the public or any portion thereof, with the intent of
furthering the purpose, either directly or indirectly, of selling professional
services, or offering to perform professional services, or inducing members
of the public to enter into any obligation relating to such professional
services.
(4)
It shall be the responsibility of any duly licensed physician who utilizes
the electronic media for the purpose of advertising to insure that an
exact copy of the audio tape and/or video tape is maintained and preserved
for a period of at least six months from the date that the actual advertisement
is aired or shown through the electronic media.
(5)
Any duly licensed physician who solicits patients personally or through
an agent shall be responsible for any advertising used to solicit such
patients. For purposes of this rule and Section 458.331(l)(1), F.S., soliciting
patients through an agent shall include accepting patients who are referred
by a corporate or business entity with whom the licensee has an employment
or contractual relationship to perform medical services or to perform
medical diagnosis, but does not include accepting patient pursuant to
managed care plans, licensed or certified by the Florida Department of
Insurance.
(6)
Any physician who advertises by, through or with a referral service shall
be held responsible for the content of such advertising and all such advertisements
shall comply with this rule and contain the following:
(a)
A statement that the advertisement is for a medical referral service
and is in the behalf of the physician members of the referral service.
(b)
A statement that the referral service refers only to those physicians
who have paid or been otherwise selected for membership in the referral
service.
(c)
A statement that membership in the referral service is limited by the
referral agency.
(d)
A statement that physicians who receive referrals from the referral
service charge no more than their usual and customary professional fees
for service.
(e)
These required statements shall be present in reasonably recognizable
print or volume equivalent to the size or volume of other information
in the advertisement.
(7)
The recognizing agencies currently approved by the Board of Medicine include:
(a)
American Board of Facial Plastic & Reconstructive Surgery, Inc.
(Approved February 1997).
(b)
American Board of Pain Medicine (Approved August 1999).
Specific
Authority 458.309 FS. Law Implemented 458.33 I(l), (d), (n), (o) FS. History--New
3-31-80, Formerly 2IM-24.01, Amended 11-15-88, Formerly 2IM-24.001, Amended
12-5-93, Formerly
6IF6-24.001,
Amended 4-3-95, 4-16-96, 5- 29-97, Formerly 59R-1 1.001, Amended 1-31-2001.
64 FL ADC 64B8-1 1. 001.
Back
to Top
64
FL ADC 64B 1 6-27.800
Rule 64BI6-27.800, F.A.C.
Fla. Admin. Code Ann. r. 64B16-27.800
Florida
Administrative Code - Annotated
Title 64. Department of Health
Subtitle 64Bl6. Board of Pharmacy
Chapter 64Bl6-27. Pharmacy Practice
64B
16-27.800 Requirement for Patient Records
(1)
A patient record system shall be maintained by all pharmacies for patients
to whom new or refill prescriptions are dispensed. The patient record
system shall provide for the immediate retrieval of information necessary
for the dispensing pharmacist to identify previously dispensed drugs at
the time a new or refill prescription is presented for dispensing. The
pharmacist shall ensure that a reasonable effort is made to obtain, record
and maintain the following information:
(a)
Full name of the patient for whom the drug is intended;
(b)
Address and telephone number of the patient;
(e)
Patient's age or date of birth;
(d)
Patient's gender;
(e)
A list of all new and refill prescriptions obtained by the patient at
the pharmacy maintaining the patient record during the two years immediately
preceding the most recent entry showing the name of the drug or device,
prescription number, name and strength of the drug, the quantity and
date received, and the name of the prescriber; and
(f)
Pharmacist comments relevant to the individuals drug therapy, including
any other information peculiar to the specific patient or drug
(2)
The pharmacist shall ensure that a reasonable effort is made to obtain
from the patient or the patient's agent and shall record any known allergies,
drug reactions, idiosyncrasies, and chronic conditions or disease states
of the patient and the identity of any other drugs, including over-the-counter
drugs, or devices currently being used by the patient which may relate
to prospective drug review. The pharmacist shall record any related information
indicated by a licensed health care practitioner.
(3)
A patient record shall be maintained for a period of not less than two
years from the date of the last entry in the profile record. This record
may be a hard copy or a computerized form.
(4)
Patient records shall be maintained for prescription dispensed subsequent
to the effective date of this regulation.
Specific
Authority 465.022, 465.0155 FS. Law Implemented 465.0155 FS. History---New
8-18-93,
Formerly 21S-27.800, 61F1O-27.800, 59X-27.800, Amended 6- 15-98.
Back
to Top
Title
XXXII - Regulation Of Professions And Occupations
Chapter 458 - Medical Practice
View
Entire Chapter
458.336
Drugs to treat obesity; rules establishing guidelines
The
Board of Medicine shall adopt rules to establish practice guidelines for
physicians to safely prescribe phentermine, fenfluramine, and other drugs
used to treat obesity.
History.--s.
188, ch. 97-264.
Back
to Top
Title
XXXII - Regulation Of Professions And Occupations
Chapter 458 - Medical Practice
View
Entire Chapter
458.3312
Specialties
A
physician licensed under this chapter may not hold himself or herself
out as a board-certified specialist unless the physician has received
formal recognition as a specialist from a specialty board of the American
Board of Medical Specialties or other recognizing agency approved by the
board. However, a physician may indicate the services offered and may
state that his or her practice is limited to one or more types of services
when this accurately reflects the scope of practice of the physician.
History.--s.
24, ch. 97-264.
Back
to Top
|
